A complete application in a minute
Tailored resume and cover letter, ready to send.
Leiden University Medical Center (LUMC) MERIT invites a doctoral candidate to study how viruses influence lipid pathways in neurons and glia, with exposure to state-of-the-art metabolomics and MS imaging. You will contribute to understanding virus-induced metabolic reprogramming and therapeutic opportunities.
The role includes 36 h/week for four years, with a competitive gross salary and training opportunities in biosecurity, ethics, and AI/LLM.
At the Leiden University Medical Center (LUMC), MERIT is looking for a doctoral candidate to work on Work Packages 1 and 2. As DC11, you will investigate how viral infections affect lipid biosynthetic pathways and explore the therapeutic targeting of lipid metabolism for controlling virus-induced neurodegeneration.
You will be guided during your research project by dr. Elena Sanchez Lopez, dr. Nina Ogrinc and prof. dr. Martin Giera.
An interest in working in a multidisciplinary research group is important for this position. You communicate clearly in English and enjoy working with researchers from different backgrounds and areas of expertise. Furthermore, you have:
You must not have resided, carried out work or studied in the Netherlands for more than 12 months in the 36 months immediately before 1 April 2027.
Fixed-term contract: duration education.
You are entitled to an end-of-year bonus (8.3%), holiday allowance, a bicycle scheme, sports allowance, home-working compensation and an excellent commuting reimbursement scheme. As an employee of LUMC, you will also be enrolled in the ABP pension fund. This means that 70% of your pension contribution is paid by LUMC.
MERIT (MEtabolic Reprogramming in viral pathogenesis: from Infection to Therapeutic innovations) is an EU-funded MSCA training programme aimed at better understanding how viruses affect the human body. Coordinated by dr. Adithya Sridhar, Assistant Professor, and prof. dr. Dasja Pajkrt, Professor of Pediatric Infectious Diseases, from the OrganoVIR Labs at Amsterdam UMC (location AMC), this project brings together seven academic institutions and 12 associated partners from across Europe.
Within MERIT, researchers will take a new, holistic approach that focuses on infections and host metabolism to unravel virus-induced metabolic reprogramming and its impact on human health. The project’s objective lies in understanding the complex interplay between viruses and host cells, focusing on metabolic reprogramming and the long-term consequences of infection. This will be achieved by combining three methodological pillars: human organoids, integrative and spatial omics, and advanced microscopy.
The Center for Proteomics and Metabolomics (CPM) at LUMC is the technological expertise center and innovation partner of the LUMC in the analysis of proteins, metabolites, lipids and glycan structures from biological materials such as cells and tissues. Mass spectrometry is the core technology within CPM and is complemented by nuclear magnetic resonance (NMR) and advanced miniaturised separation techniques. You will join the Metabolomics and Mass Spectrometry Imaging groups.